Skip to content

Zimbabwe observes a reduction in HIV prevalence, but why?

Modelling study predicts efficacy and cost-effectiveness of HIV treatment after single-dose nevirapine

AmfAR funds 'bold' viral eradication studies

US activists 'applaud' darunavir (Prezista, TMC114) pricing

Malnourishment at time HIV treatment is started equals much poorer survival

Mortality and causes of death amongst people taking HIV treatment in Senegal examined

Untested HIV-positive individuals account for up to 70% of sexually transmitted HIV infections in US, estimates CDC

AZT/3TC/tenofovir regimen effective first-line therapy in resource-limited settings

Cigarette smoking may undermine benefits of potent antiretroviral therapy